Global CD244 (2B4) Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global CD244 (2B4) Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
CD244 (2B4) Antibody is an antibody directed against the CD244 protein in the human immune system.
CD244 (2B4) Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD244 (2B4) Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from ELISA and Western Blot are the major drivers for the industry.
CD244 is a cell surface molecule that belongs to the immunoglobulin superfamily and is mainly expressed on natural killer cells, T cells and certain subsets of B cells. By binding to the CD244 molecule, this antibody can regulate the activation, proliferation and function of immune cells, thereby affecting the regulation and effect of the immune response. Since CD244 plays an important role in regulating immune cell interactions, the potential application of CD244 antibodies in immunotherapy research and the treatment of tumors, autoimmune diseases and other diseases has attracted much attention.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD244 (2B4) Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Thermo Fisher
BioLegend
Abbexa
Abcam
Cell Signaling Technology, Inc.
Arigo Biolaboratories Corp.
Boster Biological Technology
GeneTex
MyBiosource, Inc.
CUSABIO
Creative Diagnostics
Bio-Techne
AMSBIO
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
ELISA
Western Blot
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD244 (2B4) Antibody market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CD244 (2B4) Antibody introduction, etc. CD244 (2B4) Antibody Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of CD244 (2B4) Antibody market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
CD244 (2B4) Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD244 (2B4) Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from ELISA and Western Blot are the major drivers for the industry.
CD244 is a cell surface molecule that belongs to the immunoglobulin superfamily and is mainly expressed on natural killer cells, T cells and certain subsets of B cells. By binding to the CD244 molecule, this antibody can regulate the activation, proliferation and function of immune cells, thereby affecting the regulation and effect of the immune response. Since CD244 plays an important role in regulating immune cell interactions, the potential application of CD244 antibodies in immunotherapy research and the treatment of tumors, autoimmune diseases and other diseases has attracted much attention.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD244 (2B4) Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Thermo Fisher
BioLegend
Abbexa
Abcam
Cell Signaling Technology, Inc.
Arigo Biolaboratories Corp.
Boster Biological Technology
GeneTex
MyBiosource, Inc.
CUSABIO
Creative Diagnostics
Bio-Techne
AMSBIO
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
ELISA
Western Blot
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD244 (2B4) Antibody market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CD244 (2B4) Antibody introduction, etc. CD244 (2B4) Antibody Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of CD244 (2B4) Antibody market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices